A potent antimalarial activity of 5-fluoroorotate in combination with sulfamonomethoxine against Plasmodium falciparum in vitro and Plasmodium berghei in mice

Parasitology International

Volumn 47, Issue 1, 1998, Pages 59-67

  Kim, Hye Sook ^a   Miyake, Hirofumi ^a   Arai, Meiji ^a   Wataya, Yusuke ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

5 Fluoroorotate; Antimalarial agent; Combination chemotherapy; P. berghei; P. falciparum; Sulfamonomethoxine

Indexed keywords

FLUOROOROTIC ACID; SULFAMONOMETHOXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MIXTURE; DRUG SCREENING; MALE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 0031969322     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(98)00003-8     Document Type: Article

References (24)

1. Slater, A. (1993) Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57, 203-235.
2. Bosch, L., Harbers, E. and Heidelberger, C. (1958) Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro. Cancer Res. 18, 335-343.
3. Gero, A.M. and O'Sullivan, W.J. (1990) Purines and pyrimidines in malaria parasites. Blood Cells 16, 467-484.
4. Gero, A.M. and O'Sullivan, W.J. (1990) Purines and pyrimidines in malaria parasites. Blood Cells 16, 485-495.
5. Seymour, K.K., Lyons, S.D., Phillips, L., Rieckmann, K.H. and Christopherson, R.I. (1994) Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry 33, 5268-5274.
6. Reyes, P., Rathod, P.K., Sanchez, D.J., Mrema, J.E.K., Rieckmann, K.H. and Heidrich, H. (1982) Enzymes of purine and pyrimidine metabolism from the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 5, 275-290.
7. Sherman, I.W.(1979) Biochemistry of Plasmodium (malaria parasites). Microbiol. Rev. 43, 453-495.
8. Rathod, P.K., Khatri, A., Hubbert, T. and Milhous, W.K. (1989) Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 33, 1090-1094.
9. Rathod, P.K. Leffers, N.P. and Young, R.D. (1992) Molecular targets of 5-fluoroorotate in the human malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 36, 704-711.
10. Rathod, P.K. and Gomez, Z.M. (1991) Plasmodiumyoelii: Oral delivery of 5-fluoroorotate to treat malaria in mice. Exp. Parasitol. 73, 512-514.
11. Gomez, Z.M. and Rathod, P.K. (1990) Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice. Antimicrob. Agents Chemother. 34, 1371-1375.
12. Yoneyama, T., Tsutsumi, Y., Tsunoda, K. and Yamamura, Y. (1970) Antimalarial property of 4-methoxy-6-sulfanilamido-pyrimidine monohydrate (sulfamonomethoxine: DJ-1550) and its effect on the chloroquine-resistant malaria. Arzneim.-Forsch. 20, 1206-1210.
13. Brooks, D.R., Wang, P., Read, M., Watkins, W.M., Sims, P.F.G. and Hyde, J.E. (1994) Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224, 397-405.
14. Wang, P., Brooks, D.R., Sims, P.F.G. and Hyde, J.E. (1995) A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 71, 115-125.
15. Asahi, H. and Kanazawa, T. (1994) Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitology 109, 397-401.
16. Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C. and Wataya, Y. (1987) Deoxyribonucleoside triphosphate imbalance. 5-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem. 262, 8235-8241.
17. Berenbaum, M.C. (1978) A method for testing for synergy with any number of agents. J. Infect. Dis. 137, 122-130.
18. McConkey, G.A., Ittarat, I., Meshnick, S.R. and McCutchan, T.F. (1994) Auxotrophs of Plasmodium falciparum depend on p-aminobenzoic acid for growth. Proc. Natl. Acad. Sci. USA 91, 4241-44248.
19. Canfield, C.J., Pudney, M. and Gutteridge, W.E. (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80, 373-381.
20. Peters, W., Richards, W.H.G., Antimalarial drugs II, in: W. Peters, W.H.G. Richards (Eds.), Current Antimalarials and New Drug Developments, Springer-Verlag, Berlin, 1984, pp. 499-509.
21. Peters, W. (1968) The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. Part 2. Schizontocidal action in the albino mouse. Ann. Trop. Med. Parasitol. 63, 488-494.
22. Meshnick, S.R., Taylor, T.E. and Kamchonwongpaisan, S. (1996) Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy. Microbiol. Rev. 60, 301-315.
23. Ullman, B., Lee, M., Martin, D.W., Jr. and Santi, D.V. (1978) Cytotoxicity of 5-fluoro-2′-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. Proc. Natl. Acad. Sci. USA 75, 980-983.
24. Ivanetich, K.M. and Santi, D.V. (1990) Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa. FASEB J. 4, 1591-1597